Institute for Bioscience and Biotechnology Research , University of Maryland , 9600 Gudelsky Drive , Rockville , Maryland 20850 , United States.
Department of Cell Biology and Molecular Genetics , 1109 Microbiology Building , University of Maryland , College Park , Maryland 20742 , United States.
Biomacromolecules. 2018 Aug 13;19(8):3467-3478. doi: 10.1021/acs.biomac.8b00785. Epub 2018 Jul 13.
Novel oppositely charged polyphosphazene polyelectrolytes containing grafted poly(ethylene glycol) (PEG) chains were synthesized as modular components for the assembly of biodegradable PEGylated protein delivery vehicles. These macromolecular counterparts, which contained either carboxylic acid or tertiary amino groups, were then formulated at near physiological conditions into supramolecular assemblies of nanoscale level, below 100 nm. Nanocomplexes with electroneutral surface charge, as assessed by zeta potential measurements, were stable in aqueous solutions, which suggests their compact polyelectrolyte complex "core"-hydrophilic PEG "shell" structure. Investigation of PEGylated polyphosphazene nanocomplexes as agents for noncovalent PEGylation of the therapeutic protein l-asparaginase (L-ASP) in vitro demonstrated their ability to dramatically reduce protein antigenicity, as measured by antibody binding using enzyme linked immunosorbent assay (ELISA). Encapsulation in nanocomplexes did not affect enzymatic activity of L-ASP, but improved its thermal stability and proteolytic resistance. Gel permeation chromatography (GPC) experiments revealed that all synthesized polyphosphazenes exhibited composition controlled hydrolytic degradability in aqueous solutions at neutral pH and showed greater stability at lower temperatures. Overall, novel hydrolytically degradable polyphosphazene polyelectrolytes capable of spontaneous self-assembly into PEGylated nanoparticulates in aqueous solutions can potentially enable a simple and effective approach to modifying therapeutic proteins without the need for their covalent modification.
新型带相反电荷的聚膦腈高分子电解质,其中含有接枝的聚(乙二醇)(PEG)链,被合成作为组装可生物降解的 PEG 化蛋白递药载体的模块化组件。这些含有羧酸或叔氨基的大分子,然后在接近生理条件下,自组装成纳米级别的超分子组装体,尺寸小于 100nm。通过zeta 电位测量评估,纳米复合物具有电中性表面电荷,在水溶液中稳定,这表明其具有紧凑的聚电解质复合物“核”-亲水性 PEG“壳”结构。研究 PEG 化聚膦腈纳米复合物作为治疗性蛋白天冬酰胺酶(L-ASP)非共价 PEG 化的试剂,体外实验表明其能够显著降低蛋白质抗原性,这可以通过酶联免疫吸附测定(ELISA)测量抗体结合来评估。封装在纳米复合物中不会影响 L-ASP 的酶活性,但提高了其热稳定性和抗蛋白水解能力。凝胶渗透色谱(GPC)实验表明,所有合成的聚膦腈在中性 pH 值的水溶液中均表现出组成控制的可水解降解性,并且在较低温度下更稳定。总的来说,新型可水解的聚膦腈高分子电解质能够在水溶液中自发自组装成 PEG 化的纳米颗粒,这可能为修饰治疗性蛋白提供一种简单有效的方法,而无需对其进行共价修饰。